ANO4

anoctamin 4, the group of Anoctamins

Basic information

Region (hg38): 12:100717526-101128641

Previous symbols: [ "TMEM16D" ]

Links

ENSG00000151572 ∙ NCBI:121601 ∙ OMIM:610111 ∙ HGNC:23837 ∙ Uniprot:Q32M45 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

• complex neurodevelopmental disorder (Moderate), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANO4 gene.

• not_specified (75 variants)
• not_provided (5 variants)
• Developmental_and_epileptic_encephalopathy (5 variants)
• Temporal_lobe_epilepsy (1 variants)
• ANO4-related_disorder (1 variants)
• Generalized_epilepsy_with_febrile_seizures_plus (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANO4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001286615.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Effect	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous					1	1
missense	6	1	78	1		86
nonsense						0
start loss						0
frameshift						0
splice donor/acceptor (+/-2bp)						0
Total	6	1	78	1	1

Highest pathogenic variant AF is 0.000003727236

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
ANO4	protein_coding	protein_coding	ENST00000392979	25	411116

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.000322	1.00	125702	0	46	125748	0.000183

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	2.53	344	504	0.682	0.0000266	6070
Missense in Polyphen		157	230.72	0.68049		2741
Synonymous	2.04	141	175	0.804	0.00000930	1648
Loss of Function	5.20	19	63.8	0.298	0.00000369	695

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.000764	0.000763
Ashkenazi Jewish	0.000106	0.0000992
East Asian	0.0000544	0.0000544
Finnish	0.000139	0.000139
European (Non-Finnish)	0.000196	0.000193
Middle Eastern	0.0000544	0.0000544
South Asian	0.0000692	0.0000653
Other	0.00	0.00

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide. Does not exhibit calcium-activated chloride channel (CaCC) activity. {ECO:0000250|UniProtKB:Q8C5H1}.
• Pathway: Stimuli-sensing channels;Ion channel transport;Transport of small molecules (Consensus)

Recessive Scores

• pRec: 0.133

Intolerance Scores

• loftool: 0.811
• rvis_EVS: -0.78
• rvis_percentile_EVS: 12.97

Haploinsufficiency Scores

• pHI: 0.339
• hipred: Y
• hipred_score: 0.685
• ghis: 0.584

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.0483

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Ano4

Gene ontology

• Biological process: chloride transport;ion transmembrane transport;calcium activated phosphatidylserine scrambling;calcium activated phosphatidylcholine scrambling;calcium activated galactosylceramide scrambling
• Cellular component: plasma membrane;integral component of membrane
• Molecular function: intracellular calcium activated chloride channel activity;phospholipid scramblase activity;protein dimerization activity